Lu, Y., Bader, J., Xu, C., Xu, L., DeMars, L., Method, M., Westin, E. H., Xu, H. (2026). Identifying optimized dosage for zelenectide pevedotin in locally advanced/metastatic urothelial carcinoma (la/mUC) using quantitative analyses.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.4567